Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STM vs MRNA✓SelectedUSD · MRNASTM vs MRNA performance historyLatest closeAs of-4.71%11/16
Stock and ETF performance explorer

STM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-26.7%
MRNA return
+330.7%
Excess return
-357.5%
Maximum drawdown
-49.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.7%-3.6%-1.1%-4.7%
7D0.0%-20.0%+20.0%0.0%
30D-1.9%-1.3%-0.6%-1.8%
3M-17.8%+240.0%-257.8%-16.1%
All-26.7%+330.7%-357.5%-32.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling